Filing Details

Accession Number:
0001206386-12-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-08 16:15:40
Reporting Period:
2012-11-06
Filing Date:
2012-11-08
Accepted Time:
2012-11-08 16:15:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206386 M Richard Marsh 320 Wakara Way
Salt Lake City UT 84108
E.v.p., General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-06 21,096 $7.27 45,125 No 4 M Direct
Common Stock Disposition 2012-11-06 21,096 $29.05 24,029 No 4 S Direct
Common Stock Acquisiton 2012-11-06 41,804 $8.63 65,833 No 4 M Direct
Common Stock Disposition 2012-11-06 41,804 $29.05 24,029 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-11-06 21,096 $0.00 21,096 $7.27
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-11-06 41,804 $0.00 41,804 $8.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-09-14 No 4 M Direct
0 2016-02-16 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.